$SMTC Cashflow Statement | Understand Stock

$SMTC

$146.97 +$2.62 (1.82%) Close

$SMTC Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements Of Cash Flows

In millions of USD, except per-share amounts

	FY2026 12 months to Jan 25, 2026	FY2025 12 months to Jan 26, 2025	FY2024 12 months to Jan 28, 2024	FY2023 12 months to Jan 29, 2023	FY2022 12 months to Jan 30, 2022
Cash flows from operating activities:
Net loss
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Depreciation and amortization
Amortization of right-of-use assets
Right-of-use asset impairment
Investment impairments and credit loss reserves, net
Impairment of goodwill
Intangible impairment
Accretion of deferred financing costs and debt discount
Write-off of deferred financing cost and debt discount
Loss on extinguishment of debt
Induced conversion expense
Interest rate swap termination
Deferred income taxes
Share-based compensation
Loss (gain) on disposition of business operations and assets
Changes in the fair value of contingent earn-out obligations
Equity in net (gains) losses of equity method investments
Gain from sale of investments
Corporate owned life insurance, net
Amortization of inventory step-up
Changes in assets and liabilities:
Accounts receivable, net
Inventories
Other assets
Accounts payable
Accrued liabilities
Income taxes payable
Other liabilities
Net cash provided by (used in) operating activities

Cash flows from investing activities:
Proceeds from sales of property, plant and equipment
Purchase of property, plant and equipment
Proceeds from sale of investments
Purchase of investments
Purchase of intangibles
Acquisition, net of cash acquired
Proceeds from corporate-owned life insurance
Premiums paid for corporate-owned life insurance
Net cash used in investing activities
Cash flows from financing activities:
Proceeds from revolving line of credit
Payments of revolving line of credit
Proceeds from term loans
Payments of term loans
Proceeds from convertible senior notes
Proceeds from sale of warrants
Purchase of convertible note hedge
Payments of convertible senior notes
Repurchase of warrants
Proceeds from unwind of convertible note hedge
Purchase of capped calls
Proceeds from interest rate swap termination
Deferred financing costs
Payments of earn-out
Payments for employee share-based compensation payroll taxes
Proceeds from exercise of stock options
Repurchase of common stock
Contributions from Noncontrolling Interest
Distributions to noncontrolling interest
Net cash (used in) provided by financing activities

Effect of foreign exchange rate changes on cash and cash equivalents
Net increase (decrease) in cash and cash equivalents
Cash and cash equivalents at beginning of period
Cash and cash equivalents at end of period
Supplemental disclosure of cash flow information
Interest paid
Income taxes paid
Non-cash items
Capital expenditures in accounts payable
Accrued deferred financing costs
Accrued purchase of intangibles
Debt extinguished in exchange for common stock
Conversion of note into equity
Write-off of deferred financing costs pursuant to induced conversion

Comments